AB 753

  • Wisconsin Assembly Bill
  • 2023-2024 Regular Session
  • Introduced in Assembly Dec 06, 2023
  • Assembly
  • Senate
  • Governor

Relating to: creating a medicinal psilocybin treatment fund and a pilot program to study the effects of medicinal psilocybin treatment on patients with post-traumatic stress syndrome at the University of Wisconsin-Madison and making an appropriation. (FE)

Votes


No votes to display

Actions


Apr 15, 2024

Assembly

Failed to pass pursuant to Senate Joint Resolution 1

Jan 12, 2024

Assembly

Fiscal estimate received

Dec 15, 2023

Assembly

Representative Madison added as a coauthor

Dec 06, 2023

Assembly

Introduced by Representatives Gustafson, C. Anderson, Brooks, Edming, Murphy, Sapik, J. Anderson, Bare, Considine, Emerson, Jacobson, Joers, Ohnstad, Ortiz-Velez, Ratcliff, Shankland, Sinicki and Haywood; cosponsored by Senators James, Hesselbein, Agard, Larson, Roys and Spreitzer

Assembly

Read first time and referred to Committee on Health, Aging and Long-Term Care

Bill Text

Bill Text Versions Format
Bill Text PDF HTML

Related Documents

Document Format
2023 Senate Bill 727 HTML
Wisconsin Ethics Commission information HTML
AB753 ROCP for Committee on Health, Aging and Long-Term Care HTML
AB753: Fiscal Estimate From UWS

Sources

Data on Open States is updated periodically throughout the day from the official website of the Wisconsin State Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.